Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children

NCT03582384 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03582384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03582384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children
Lead sponsor
Boston Children's Hospital
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2020
Completion date
January 31, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

short bowel syndrome, vitamin e deficiency